It was evidenced that inhibition of autophagy in ovarian cancer stem cells decreased the size and number of sphere formation, reduce the population of CD24− and CD44+ cells, increased drug sensitivity to paclitaxel and attenuates the expression of FOXA2 [95]. Here, FOXA2 is linked to ovarian carcinoma.